DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main Stock

Certificat

DE000DDZ1CV1

Real-time Boerse Frankfurt Warrants 11:35:02 2024-06-28 EDT
635.1 EUR +1.71% Intraday chart for DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main
Current month-4.29%
1 month-7.28%
Date Price Change
24-06-28 635.1 +1.71%
24-06-27 624.5 +1.32%
24-06-26 616.4 -3.13%
24-06-25 636.3 +0.31%
24-06-24 634.3 +1.59%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 11:35 am

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying PFIZER, INC.
Issuer DZ BANK
WKN DDZ1CV
ISINDE000DDZ1CV1
Date issued 2022-11-07
Strike 46.55 $
Maturity 2029-04-30 (1767 Days)
Parity 0.05 : 1
Emission price 1,000
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 1,006
Lowest since issue 551.6

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.8 USD
Average target price
31.92 USD
Spread / Average Target
+14.80%
Consensus